At a glance
ClinicalIndex Comparison RecordN/ACompleted· 180 enrolled
Drug / intervention
2L PEG-ELS +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Single-blinded, Comparative Study to Evaluate the Efficacy and the Acceptability of Low-residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy
In Brief
A clinical study evaluating Enimaclin®, Self-controlled diet, and 2 other interventions for Dietary Modification. Completed, enrolled 180 participants across 4 sites.
Detailed Summary
The purpose of this study is to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDietary Modification
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
Primary CompletionJun 2012
First PostedAug 2012
TodayJul 2026
First PostedAug 15, 2012
Enrollment StartNov 1, 2011
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 13.9 years ago
Interventions
Enimaclin®dietary
Enimaclin Colomil ® (Glico Co., Japan Osaka)，a low-residue diet package for each meal. The duration of study is one day before colonoscopy.
Self-controlled dietother
Self-controlled low residue diet.
2L PEG-ELSdrug
Normal volume of PEG-ELS
low volume 1.5L PEG-ELSdrug
Low volume PEG-ELS